Aclarion, Inc.(ACON), a healthcare technology company, said on Wednesday that its board has authorized a share repurchase program of up to $2.5 million of shares. The company plans to execute the share repurchase drive over the next 12 months.
Brent Ness, CEO of Aclarion, said: "We believe our shares represent a compelling value at current levels, and we view this program as a flexible and opportunistic tool to enhance shareholder value while continuing to invest in the clinical adoption and expansion of Nociscan."
Aclarion intends to fund this repurchase program using existing cash and cash equivalents.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.